RadNet Inc. (RDNT)
NASDAQ: RDNTHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RDNT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.49B
- Forward P/E
- 66.39
- EPS (TTM)
- -$0.29
- Dividend yield
- None
- 52-week range
- 50.82 – 85.84
- Day range
- 68.00 – 70.86
- Volume / Avg
- 594.24K / 688.04K
- Beta
- —
- Shares outstanding
- 78.77M
52-week range
RDNT stock today
Shares of RadNet (RDNT) finished higher on Nov 20 at $69.71, a gain of 0.29% or $0.20 per share, versus the S&P 500's 3.70% decline. At this level, RDNT sits in the middle of its 52-week range of $50.82 to $85.84: 18.8% below the high, set on Nov 25, 2025 and 37.2% above the low. RDNT is down 2.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 16.0%.
RadNet has posted a net loss over the last twelve months (EPS of -$0.29), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About RadNet
Company profileRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Dr. Howard G. Berger M.D.
- Headquarters
- Los Angeles, CA
- Employees
- 12,000
- Website
- radnet.com
Financial highlights
Full financialsIn fiscal 2025, RadNet generated $2.04 billion in revenue, up 11.5% from fiscal 2024, its 5th consecutive year of revenue growth. RadNet reported a net loss of $18.7 million, compared with net income of $2.8 million a year earlier. Operating margin was 3.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.04B | $1.83B | $1.62B | $1.43B | $1.32B |
| Growth | +11.51% | +13.18% | +13.05% | +8.74% | +22.69% |
| Net income | $-18.65M | $2.79M | $3.04M | $10.65M | $24.73M |
| EPS (diluted) | $-0.25 | $0.04 | $0.05 | $0.17 | $0.46 |
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$97.00+39.15%
- Strong buy 2
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 9, 2026
- EPS actual vs est.
- $0.05 vs $0.21
- Surprise
- -76.19%
RDNT news
All RDNT news- RadNet: 3 Key Takeaways for Long-Term InvestorsNasdaq
- RadNet (RDNT) Q3 2026 Earnings Call TranscriptNasdaq
- RadNet, Inc. Reports Record Third Quarter 2026 Revenue of $638.3 Million and Raises Full-Year GuidanceNasdaq
- RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance RangesGlobeNewswire
- Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass EstimatesNasdaqELAN, RDNT
- RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings GrowthNasdaqRDNT, ELAN
- RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference CallGlobeNewswire
- RadNet, Inc. Enters Merger Agreement to Acquire OnRad, Inc. for $350,000,000 in Cash and 5,000,000 SharesNasdaq
RadNet peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CONConcentra Group Holdings Parent Inc. | 41.84 | +0.94% | $5.26B | vs RDNT |
| CAICaris Life Sciences Inc. | 17.58 | -5.18% | $5.04B | vs RDNT |
| GRALGRAIL Inc. | 99.25 | -5.33% | $4.46B | vs RDNT |
| BLLNBillionToOne Inc. Class A | 89.92 | -0.31% | $4.30B | vs RDNT |
| CDNACareDx Inc. | 70.00 | -2.67% | $3.68B | vs RDNT |
| OSCROscar Health Inc. Class A | 24.73 | -5.50% | $7.68B | vs RDNT |
| ACHCAcadia Healthcare Company Inc. | 34.60 | +0.38% | $3.22B | vs RDNT |
| CELCCelcuity Inc. | 53.35 | -5.26% | $2.61B | vs RDNT |
Indexes, lists and sector
RadNet stock FAQ
What is RadNet's stock price today?
RDNT last traded at $69.71 as of Nov 20, 4:00 PM EST, up 0.29% on the day. Prices are delayed at least 15 minutes.
Does RadNet pay a dividend?
No. RadNet does not currently pay a regular cash dividend.
Who is RadNet's CEO?
Dr. Howard G. Berger M.D. is the chief executive officer of RadNet Inc., which has about 12,000 employees.
Has RDNT ever split its stock?
Yes. The most recent RDNT stock split was a 1-for-2 split on Nov 28, 2006.
What is the RDNT 52-week high?
The 52-week high for RDNT is $85.84 and the 52-week low is $50.82. The stock is currently 18.8% below its high.